Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04405700 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04405700 · ClinicalTrials.gov record · last posted 2026-08-24

Measuring Adverse Pregnancy and Newborn Congenital Outcomes

Name: Measuring Adverse Pregnancy and Newborn Congenital Outcomes — clinical trial record (NCT04405700)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MANGO

StatusRecruiting

PhaseNot specified

SponsorIndiana University

Started2020-09-29

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of this study is to develop a pharmacovigilance (PV) surveillance program to monitor adverse pregnancy and infant outcomes, including the presence of congenital abnormalities, among HIV-positive and HIV-negative women and their infants at clinical sites affiliated with the International Epidemiology Databases to Evaluate consortium (IeDEA).

Protocol amendment history 2 changes detected by DataLookout

2026-08-25

Primary completion pushed: 2026-05-31 → 2031-05-31

2026-08-25

Completion pushed: 2026-05-31 → 2031-05-31

Trial Details

NCT Number	NCT04405700
Lead Sponsor	Indiana University
Conditions	HIV/AIDS, Pregnancy Related, Congenital Disorders, Newborn Morbidity
Enrollment	2,800 participants
Start Date	2020-09-29
Primary Completion	2031-05-31 (estimated)
Study Completion	2031-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-24